The use of β-blockers in the first trimester of pregnancy may not greatly increase the risk for major congenital malformations in offspring.
Intensive BP therapy is associated with significantly lower risk for cardiovascular events based on data reweighted to better reflect the US adult population with diabetes.
Implementing the updated ACC/AHA guideline would direct antihypertensive medications to adults with high risk of cardiovascular disease.
The Southern dietary pattern is the largest mediating factor for differences in the incidence of hypertension in black men and women.
An association was found between increased systolic blood pressure and risk for aortic stenosis and regurgitation.
A greater proportion of patients with dysautonomia had supine hypertension compared with patients without dysautonomia.
Adding history of hypertensive disorders of pregnancy to the current cardiovascular disease (CVD) risk score does not improve CVD prediction in low-risk women.
The overall impact of intensive blood pressure control led to beneficial effects on cardiovascular outcomes across the spectrum of BMI models.
The primary outcome was an unfavorable neurologic outcome, which was defined as a modified Rankin Scale score of 3 to 6 at 3 months following randomization.
Triple combination antihypertension therapy improves blood pressure control for mild-to-moderate hypertensionSeptember 21, 2018
In this randomized controlled trial, patients receiving triple combination antihypertension therapy (TCAT) were more likely to achieve their blood pressure target compared to those with usual care at 6 months.
Fourteen percent of older adults hospitalized with non-cardiac conditions are discharged with intensified antihypertensive treatment, of whom more than half had previously well-controlled outpatient blood pressure.
Individuals who would now be classified as having stage 1 hypertension according to the new American College of Cardiology/American Heart Association blood pressure guidelines also have an increased risk for cardiovascular events.
Users of valsartan contaminated with N-nitrosodimethylamine seem not to have increased cancer risk.
The FDA warns that it has found a second impurity in three lots of Torrent Pharmaceuticals' valsartan drug products.
In July, several valsartan medications were recalled due to the detection of N-nitrosodimethylamine, an impurity classified as a probable human carcinogen.
Intensive blood pressure therapy is associated with a significantly lower risk for serious cardiovascular events in the adults with diabetes.
Single-pill, fixed-dose combination treatment may be more effective for improving blood pressure control in older patients.
A correct diagnosis of resistant hypertension is necessary to avoid overmedicating.
Mortality benefits from atorvastatin- and amlodipine-based antihypertensive treatments extend beyond 10 years of treatment.
The presence of heart disease and hypertension may contribute to advanced brain atrophy in patients with multiple sclerosis.
The risk of a mixing-up the treatments is especially high for pregnant women, says the Food and Drug Administration (FDA), as losartan is indicated to treat high blood pressure and could harm or kill a fetus.
A guideline-based approach directing pharmacological treatment to adults more likely to have CVD events may maximize absolute risk reduction of treatment.
Clinicians weigh in on appropriate blood pressure goals for a 79-year-old man with a mean blood pressure of 147/67 mm Hg.
The increase in blood pressure ranged from 0.8 to 1.7 mm Hg per unit BMI in patients who were not taking antihypertensive medication.
To date, there have been no reports of any adverse events related to this recall.
New study suggests sodium intake is associated with cardiovascular disease and stroke only when mean sodium intake exceeds 5 grams per day.
First-trimester HbA1c significantly improved gestational diabetes prediction compared with conventional risk factors.
Children who were born as extreme preterm infants may have a higher risk for high blood pressure and hypertension.
This case involved a 36-year-old female with bipolar disorder who presented to the emergency department (ED) with blurry vision, neck stiffness and the "worst headache of (her) life" after taking armodafinil with tranylcypromine.
The proportion of patients achieving target blood increased with the use of a triple combination pill vs usual care at 6 months.
The Cardiology Advisor Articles
- Class 1 Device Recall: Endologix AFX Device Recalled Due to Type III Endoleaks
- Harvard: Fraudulent Data Found in Publications of Heart Researcher
- Traumatic Life Events May Increase Risk for Atrial Fibrillation in Older Women
- No Differences Between Bivalirudin, UFH Post-PCI After Ticagrelor Pretreatment
- Rivaroxaban Approved to Reduce Risk of Major Cardiovascular Events in CAD, PAD
- Coenzyme Q10 Supplementation May Reduce Statin-Induced Myopathy
- Long-Term Exposure to Elevated BP Associated With AS and AR
- Risk Factors for Atherosclerotic Cardiovascular Disease in the South Asian Population
- Takotsubo Syndrome Associated With Substantial Morbidity, Mortality
- Bariatric Surgery Reduces Macrovascular Complications in Obesity, T2D
- Metformin May Improve Vascular Health in Adolescents With Type 1 Diabetes
- Improved Cardiovascular Event Reporting Needed in Leukemia Clinical Trials
- Psoriasis Associated With Clinical Signs of Accelerated Atherosclerosis
- Can Dermatoscope Magnets Be Used With CV Implanted Electronic Devices?
- The Striking Effects of Diversity in Health Care: Improving Patient Outcomes